BCYC vs COST · rev $1.5M vs P/E 55, rev $275.24B
Bicycle Therapeutics Ltd (BCYC) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
BCYC currently screens at market cap $554.0M. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the BCYC and COST stock pages for the full models.
Not investment advice.